福瑞达: 鲁商福瑞达医药股份有限公司第十二届董事会独立董事专门会议决议

Core Viewpoint - The independent directors of Lushang Furuida Pharmaceutical Co., Ltd. convened a special meeting to review and approve a risk assessment report regarding Shandong Provincial Commercial Group Financial Co., Ltd., concluding that there are no significant deficiencies in its risk management [1][2]. Group 1 - The special meeting of the independent directors was held on August 19, 2025, and was legally valid as per relevant regulations [1]. - The independent directors unanimously approved the risk assessment report, which reflects the operational qualifications, internal controls, management, and risk management status of Shandong Provincial Commercial Group Financial Co., Ltd. [2]. - The report indicates that Shandong Provincial Commercial Group Financial Co., Ltd. is under strict supervision by the China Banking and Insurance Regulatory Commission, ensuring its business scope and internal risk control measures are adequately managed [2].